Inovio Pharmaceuticals Inc. said the company’s Covid-19 vaccine candidate was safe, well-tolerated and produced immune response against the new coronavirus in a mid-stage clinical trial, sending the drug developer’s shares up over 3 percent.
If you are not happy with the results below please do another search
50 search results for:
U.S. regulators on May 10 authorized Pfizer and BioNTech’s Covid-19 vaccine for use in children as young as 12 years and said they could begin receiving shots as soon as May 11, widening the country’s inoculation program as vaccination rates have slowed significantly.
India on May 8 reported a record one-day rise in Covid-19 deaths as cases surged by more than 400,000 for the third consecutive day.
The World Health Organization (WHO) approved for emergency use a Covid-19 vaccine from China’s state-owned drugmaker Sinopharm on May 7, bolstering Beijing’s push for a bigger role in inoculating the world.
The U.S. Centers for Disease Control and Prevention (CDC) said on May 7 that U.S.-bound international air travelers can meet Covid-19 entry requirements using certain self-administered tests.
The European Commission called on May 7 on the United States and other major Covid-19 vaccine producers to export what they make as the European Union does, rather than talk about waiving intellectual property rights to the shots.
Six months after receiving Emergency Use Authorization from the U.S. Food and Drug Administration for Covid-19 vaccines, Pfizer/BioNTech and Moderna are seeking full approval for the preventative medications. Pfizer and BioNTech announced on May 7 that they initiated a rolling submission of a Biologics License Application with the FDA for full approval of their mRNA vaccine in individuals 16 years and older.
A preliminary study conducted by the Israeli government suggests that there may be a connection between heart inflammation—myocarditis—and the Pfizer-BioNTech Covid-19 vaccine in people between the ages of 18 and 30 years. However, the rate does not appear to be higher than in the pre-pandemic population.
Boosted by increased clinical research business in 2020, Science 37 is planning a SPAC merger that will land itself on the Nasdaq and a company value of more than $1 billion and $280 million in gross proceeds.
A study published in the journal eLife of 81 semi-supercentenarians—people 105 years of age or older—and supercentenarians—110 years or older from across Italy, were analyzed by researchers from the University of Bologna, Italy and Nestle Research in Lausanne, Switzerland. Researchers compared genetic data from these extraordinary agers to 36 healthy people from the same region whose age, on average, was 68 years.